deltatrials

Columbia University Clinical Trials

Sponsors / Columbia University

Columbia University appears as lead sponsor on 1,159 trial records in ClinicalTrials.gov. Of these, 161 are recruiting, 49 are active without new recruitment, and 735 have completed. The registry records 136 terminated or withdrawn trials for Columbia University. The most common reasons cited for termination include slow or insufficient recruitment, investigator or site changes. Planned participant enrollment across these trials sums to 1,979,561. Figures on this page are sourced from ClinicalTrials.gov and refreshed with each registry update.

1,159
Total Trials
161
Recruiting
49
Other Active
735
Completed
136
Terminated / Withdrawn
1,979,561
Total Enrollment

Termination reasons: Other38% · Recruitment30% · PI/or_Site16% · Funding13% · Regulatory2% · Safety1%

Recent Terminations

  • NCT06078696 Phase PHASE1/PHASE2 Stopped Dec 2025
    Anemia, Sickle Cell
    "Closed by the industry collaborator"
  • NCT06242847 Stopped Nov 2025
    Insulin Resistance
    "The study's collaborating dermatologist left the institution, and so skin biopsies could no longer be performed."
  • NCT05587530 Phase NA Stopped May 2025
    Suicide
    "As of 09/2025, the study was unable to be completed due to the administrative pause of research activities at the New York State Psychiatric Institute."
  • NCT05887115 Phase NA Stopped Jan 2025
    Child Development
    "Recruitment milestones not met; funding withdrawn"
  • NCT05780346 Phase NA Stopped Jul 2023
    Parent-Child Relations
    "Lack of resources and personnel available to complete study"
  • NCT05319080 Phase NA Stopped Apr 2023
    Schizophrenia and Related Disorders
    "Investigator departed from institution"
  • NCT05099926 Phase NA Stopped Feb 2023
    Acute Coronary Syndrome
    "Halted Prematurely"
  • NCT05526833 Phase NA Stopped Jan 2023
    Schizophrenia and Related Disorders
    "Investigator departed from institution"
  • NCT05298397 Phase NA Stopped Nov 2022
    Anxiety Disorder of Childhood or Adolescence
    "PI stopped study due to staff turnover, recruitment/scheduling problems, policy changes, will redesign"
  • NCT05571670 Stopped Jun 2022
    AKT Gene Mutation
    "Poor enrollment"

Active Trials (49 total)

See all 49 active trials

Top Conditions

Breast cancer (21) Stroke (17) Obesity (16) HIV (15) Depression (14) Alzheimer's disease (12) Heart failure (12) Asthma (11) HIV/AIDS (11) Acute coronary syndrome (10)

Top Locations

New York, United States (951) Philadelphia, United States (32) Boston, United States (28) Chicago, United States (22) Miami, United States (22) Rochester, United States (22) Atlanta, United States (19) Baltimore, United States (18) The Bronx, United States (17) Pittsburgh, United States (16)